Compared to patients with MODY 2, who were well-matched for hyperglycemia and obesity, patients with T1D were significantly more insulin resistant, suggesting that IR is driven by peripheral hyperinsulinemia and not hyperglycemia (34). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.